RECRUITING

Role of Sleep Reactivity in Shift Work Disorder

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this project is to test sleep reactivity as an independent cause of Shift Work Disorder (SWD). The primary hypothesis is that those with high sleep reactivity will show persistent SWD symptoms after experimental reduction of circadian misalignment, which will then be mitigated with CBT.

Official Title

Sleep Reactivity as a Novel Mechanism in Shift Work Disorder

Quick Facts

Study Start:2023-01-01
Study Completion:2027-10-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05424406

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Participants must be working a fixed nightshift schedule, operationalized as: a) working at least three night shifts a week, b) shifts must begin between 18:00 and 02:00, and last between 8 to 12 hours, and c) must also plan to maintain the nightshift schedule for the duration of the study
  2. * Participants must have Shift Work Disorder, which will be diagnosed based on ICSD-3 criteria
  3. * Participants must show circadian misalignment, operationalized as a baseline melatonin onset between 18:00 and 01:00.
  4. * Participants must be at least 18 years old
  1. * Insomnia disorder or excessive sleepiness predating the onset of shift work
  2. * Termination of nightshift schedule
  3. * Presence of other sleep disorders (e.g. obstructive sleep apnea, narcolepsy) determined by standard clinical polysomnography
  4. * Diagnosis of bipolar disorder
  5. * History of neurological disorders determined by self-report and medical history
  6. * Pregnancy
  7. * Alcohol use disorder
  8. * Illicit drug use via self-report and urine drug screen if reasonable suspicion to test

Contacts and Locations

Study Contact

Philip Cheng, PhD
CONTACT
248-344-7361
pcheng1@hfhs.org
Cynthia Fellman-Couture, RN, BSN, PhD
CONTACT
248-344-7362
cfellma1@hfhs.org

Study Locations (Sites)

Henry Ford Columbus Medical Center
Novi, Michigan, 48377
United States

Collaborators and Investigators

Sponsor: Henry Ford Health System

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-01-01
Study Completion Date2027-10-01

Study Record Updates

Study Start Date2023-01-01
Study Completion Date2027-10-01

Terms related to this study

Keywords Provided by Researchers

  • Sleep reactivity

Additional Relevant MeSH Terms

  • Shift-work Disorder